These injectable medications mimic a natural hormone called glucagon-like peptide-1 (GLP-1), which helps regulate your appetite, blood sugar levels, and digestion
Among antihypertensive agents, inhibitors of the reninangiotensinaldosterone system (RAAS)particularly Cs (ACEIs)have shown superior renal benefits
Type 2 diabetes, in particular, has seen a continuous increase in prevalence, driven by lifestyle shifts and population aging, especially in Westernized societies, where these factors contribute to rising obesity rates
Oxidation of ethanol can also occur in peroxisomes via the activity of catalase
January 2026: Amgen completed Phase 3 enrollment for MariTide (AMG 133) in the MARITIME-Obesity trial, with interim efficacy data expected in Q3 2026 that will position the monthly injection GLP-1/GIP antagonist as a once-monthly obesity treatment alternative
Brighten Essentials use code POD15 for 15% off Lumebox Support our sponsors and help keep this show free and packed with amazing guests